Discovery of Bishomo(hetero)arylpiperazines as Novel Multifunctional Ligands Targeting Dopamine D3 and Serotonin 5-HT1A and 5-HT2A Receptors-Reference-Cited by-同舟云学术

Discovery of Bishomo(hetero)arylpiperazines as Novel Multifunctional Ligands Targeting Dopamine D3 and Serotonin 5-HT1A and 5-HT2A Receptors

Published:2010-05-19 Issue:12 Volume:53 Page:4803-4807
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Butini Stefania¹²,Campiani Giuseppe¹²,Franceschini Silvia¹²,Trotta Francesco¹²,Kumar Vinod¹²,Guarino Egeria¹²,Borrelli Giuseppe¹²,Fiorini Isabella¹²,Novellino Ettore¹³,Fattorusso Caterina¹³,Persico Marco¹³,Orteca Nausicaa¹³,Sandager-Nielsen Karin⁴,Jacobsen Thomas Amos⁴,Madsen Kim⁴,Scheel-Kruger Jorgen⁴,Gemma Sandra¹²

Affiliation:

1. European Research Centre for Drug Discovery and Development, Universitá di Siena, 53100 Siena, Italy

2. Dipartimento Farmaco Chimico Tecnologico, Universitá di Siena, Via Aldo Moro, 53100 Siena, Italy,

3. Dipartimento di Chimica delle Sostanze Naturali and Dipartimento di Chimica Farmaceutica e Tossicologica, Università di Napoli Federico II, Via D. Montesano 49, 80131 Napoli, Italy

4. NeuroSearch A/S, Pederstrupvej 93, Ballerup DK-2750, Denmark

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm100294b

Reference16 articles.

1. Schizophrenia

2. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

3. Designed Multiple Ligands. An Emerging Drug Discovery Paradigm

4. Olanzapine-Associated Diabetes Mellitus

5. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pioneering first‐in‐class FAAH‐HDAC inhibitors as potential multitarget neuroprotective agents;Archiv der Pharmazie;2023-09-26

2. Mixed ligand Cd(II) coordination architectures based on bulky anthracene-9-carboxylate ligand: Crystal structures and optical properties;Inorganica Chimica Acta;2023-07

3. Development and challenges in the discovery of 5-HT1A and 5-HT7 receptor ligands;Bioorganic Chemistry;2023-02

4. Recent developments in the management of Huntington's disease;Bioorganic Chemistry;2022-03

5. Synthesis of new 4-butyl-arylpiperazine-3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives and evaluation for their 5-HT1A and D2 receptor affinity and serotonin transporter inhibition;Bioorganic Chemistry;2020-04